2,332
Views
39
CrossRef citations to date
0
Altmetric
Meeting Report

World Bispecific Antibody Summit, September 27–28, 2011, Boston, MA

&
Pages 4-13 | Received 15 Nov 2011, Accepted 15 Nov 2011, Published online: 01 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Andre A. R. Teixeira, Sara D’Angelo, M. Frank Erasmus, Camila Leal-Lopes, Fortunato Ferrara, Laura P. Spector, Leslie Naranjo, Esteban Molina, Tamara Max, Ashley DeAguero, Katherine Perea, Shaun Stewart, Rebecca A. Buonpane, Horacio G. Nastri & Andrew R. M. Bradbury. (2022) Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs. mAbs 14:1.
Read now
Sergey E Sedykh, Victor V Prinz, Valentina N Buneva & Georgy A Nevinsky. (2018) Bispecific antibodies: design, therapy, perspectives. Drug Design, Development and Therapy 12, pages 195-208.
Read now
Chunlei Wang, Bhargavi Vemulapalli, Mingyan Cao, Dhanesh Gadre, Jihong Wang, Alan Hunter, Xiangyang Wang & Dengfeng Liu. (2018) A systematic approach for analysis and characterization of mispairing in bispecific antibodies with asymmetric architecture. mAbs 10:8, pages 1226-1235.
Read now
Mingyan Cao, Chunlei Wang, Wai Keen Chung, Dana Motabar, Jihong Wang, Elizabeth Christian, Shihua Lin, Alan Hunter, Xiangyang Wang & Dengfeng Liu. (2018) Characterization and analysis of scFv-IgG bispecific antibody size variants. mAbs 10:8, pages 1236-1247.
Read now
Ulrich Brinkmann & Roland E. Kontermann. (2017) The making of bispecific antibodies. mAbs 9:2, pages 182-212.
Read now
Siqi Chen, Jing Li, Qing Li & Zhong Wang. (2016) Bispecific antibodies in cancer immunotherapy. Human Vaccines & Immunotherapeutics 12:10, pages 2491-2500.
Read now
Anke Steinmetz, François Vallée, Christian Beil, Christian Lange, Nicolas Baurin, Jochen Beninga, Cécile Capdevila, Carsten Corvey, Alain Dupuy, Paul Ferrari, Alexey Rak, Peter Wonerow, Jochen Kruip, Vincent Mikol & Ercole Rao. (2016) CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applications. mAbs 8:5, pages 867-878.
Read now
Marta Compte, Ana Álvarez-Cienfuegos, Natalia Nuñez-Prado, Noelia Sainz-Pastor, Ana Blanco-Toribio, Nuria Pescador, Laura Sanz & Luis Álvarez-Vallina. (2014) Functional comparison of single-chain and two-chain anti-CD3-based bispecific antibodies in gene immunotherapy applications. OncoImmunology 3:5.
Read now
David Ouellette, Chris Chumsae, Anca Clabbers, Czeslaw Radziejewski & Ivan Correia. (2013) Comparison of the in vitro and in vivo stability of a succinimide intermediate observed on a therapeutic IgG1 molecule. mAbs 5:3, pages 432-444.
Read now
Ivan Correia, Joyce Sung, Randall Burton, Clarissa G. Jakob, Bridget Carragher, Tariq Ghayur & Czeslaw Radziejewski. (2013) The structure of dual-variable-domain immunoglobulin molecules alone and bound to antigen. mAbs 5:3, pages 364-372.
Read now
Marta Compte, Natalia Nuñez-Prado, Laura Sanz & Luís Álvarez-Vallina. (2013) Immunotherapeutic organoids. Biomatter 3:1.
Read now
Janice M. Reichert. (2012) mAbs’s communication networks. mAbs 4:2, pages 133-133.
Read now

Articles from other publishers (26)

Hua-ying Li, Yi-li Chen, Xiang-nan Deng, Huan-huan Li, Jie Tan, Guo-jian Liu, Yu-juan Zheng, Min Pei, Kai-ting Peng, Li-li Yue, Xiao-jia Chen, Yu Liu, Yong-shan Zhao & Chun-he Wang. (2023) Bispecific antibody targeting both B7-H3 and PD-L1 exhibits superior antitumor activities. Acta Pharmacologica Sinica 44:11, pages 2322-2330.
Crossref
Luigi Liguori, Giovanna Polcaro, Annunziata Nigro, Valeria Conti, Carmine Sellitto, Francesco Perri, Alessandro Ottaiano, Marco Cascella, Pio Zeppa, Alessandro Caputo, Stefano Pepe & Francesco Sabbatino. (2022) Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors. Pharmaceutics 14:11, pages 2442.
Crossref
Jingyue Kang, Tonglin Sun & Yan Zhang. (2022) Immunotherapeutic progress and application of bispecific antibody in cancer. Frontiers in Immunology 13.
Crossref
Ingrid Grunert, Katrin Heinrich, Juliane Ernst, Michael Hingar, Alexandre Briguet, Michael Leiss, Manfred Wuhrer, Dietmar Reusch & Patrick Bulau. (2022) Detailed Analytical Characterization of a Bispecific IgG1 CrossMab Antibody of the Knob-into-Hole Format Applying Various Stress Conditions Revealed Pronounced Stability. ACS Omega 7:4, pages 3671-3679.
Crossref
Seyed Samad Hosseini, Saeed Khalili, Behzad Baradaran, Negar Bidar, Mohammad-Ali Shahbazi, Jafar Mosafer, Mahmoud Hashemzaei, Ahad Mokhtarzadeh & Michael R. Hamblin. (2021) Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials. International Journal of Biological Macromolecules 167, pages 1030-1047.
Crossref
Jian-feng Li, Yuan-yuan Niu, Yan-li Xing & Feng Liu. (2019) A novel bispecific c-MET/CTLA-4 antibody targetting lung cancer stem cell-like cells with therapeutic potential in human non-small-cell lung cancer. Bioscience Reports 39:5.
Crossref
Xiaolong Zhang, Yuanyuan Yang, Dongmei Fan & Dongsheng Xiong. (2017) The development of bispecific antibodies and their applications in tumor immune escape. Experimental Hematology & Oncology 6:1.
Crossref
Sunil Kumar, Reena Vohra Saini & Neeraj Mahindroo. (2017) Recent advances in cancer immunology and immunology-based anticancer therapies. Biomedicine & Pharmacotherapy 96, pages 1491-1500.
Crossref
Simon Krah, Carolin Sellmann, Laura Rhiel, Christian Schröter, Stephan Dickgiesser, Jan Beck, Stefan Zielonka, Lars Toleikis, Björn Hock, Harald Kolmar & Stefan Becker. (2017) Engineering bispecific antibodies with defined chain pairing. New Biotechnology 39, pages 167-173.
Crossref
T. Noelle Lombana & Christoph Spiess. 2017. Analytical Characterization of Biotherapeutics. Analytical Characterization of Biotherapeutics 169 198 .
Simon Krah, Christian Schröter, Carla Eller, Laura Rhiel, Nicolas Rasche, Jan Beck, Carolin Sellmann, Ralf Günther, Lars Toleikis, Björn Hock, Harald Kolmar & Stefan Becker. (2017) Generation of human bispecific common light chain antibodies by combining animal immunization and yeast display. Protein Engineering Design and Selection.
Crossref
Guillaume Terral, Alain Beck & Sarah Cianférani. (2016) Insights from native mass spectrometry and ion mobility-mass spectrometry for antibody and antibody-based product characterization. Journal of Chromatography B 1032, pages 79-90.
Crossref
Menghuai Xu, Haizhen Jin, Zhiguo Chen, Wei Xie, Youfu Wang, Yang Wang, Min Wang, Juan Zhang & Desmond Omane Acheampong. (2016) A novel bispecific diabody targeting both vascular endothelial growth factor receptor 2 and epidermal growth factor receptor for enhanced antitumor activity. Biotechnology Progress 32:2, pages 294-302.
Crossref
Gaowei Fan, Zujian Wang, Mingju Hao & Jinming Li. (2015) Bispecific antibodies and their applications. Journal of Hematology & Oncology 8:1.
Crossref
Christoph Spiess, Qianting Zhai & Paul J. Carter. (2015) Alternative molecular formats and therapeutic applications for bispecific antibodies. Molecular Immunology 67:2, pages 95-106.
Crossref
Rodrigo Vazquez-Lombardi, Tri Giang Phan, Carsten Zimmermann, David Lowe, Lutz Jermutus & Daniel Christ. (2015) Challenges and opportunities for non-antibody scaffold drugs. Drug Discovery Today 20:10, pages 1271-1283.
Crossref
Ming-Ru Wu, Tong Zhang, Albert T. Gacerez, Tiffany A. Coupet, Leslie R. DeMars & Charles L. Sentman. (2015) B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity. The Journal of Immunology 194:11, pages 5305-5311.
Crossref
Roeland Lameris, Renée C.G. de Bruin, Famke L. Schneiders, Paul M.P. van Bergen en Henegouwen, Henk M.W. Verheul, Tanja D. de Gruijl & Hans J. van der Vliet. (2014) Bispecific antibody platforms for cancer immunotherapy. Critical Reviews in Oncology/Hematology 92:3, pages 153-165.
Crossref
Casey W. Shuptrine & Louis M. Weiner. 2014. Advances in Tumor Immunology and Immunotherapy. Advances in Tumor Immunology and Immunotherapy 183 211 .
Hannah Byrne, Paul J. Conroy, James C. Whisstock & Richard J. O’Kennedy. (2013) A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications. Trends in Biotechnology 31:11, pages 621-632.
Crossref
Christoph Spiess, Jack BeversIIIIII, Janet Jackman, Nancy Chiang, Gerald Nakamura, Michael Dillon, Hongbin Liu, Patricia Molina, J. Michael Elliott, Whitney Shatz, Justin M. Scheer, Glen Giese, Josefine Persson, Yin Zhang, Mark S. Dennis, James Giulianotti, Prateek Gupta, Dorothea Reilly, Enzo Palma, Jianyong Wang, Eric Stefanich, Heleen Scheerens, Germaine Fuh & Lawren C. Wu. (2013) Development of a Human IgG4 Bispecific Antibody for Dual Targeting of Interleukin-4 (IL-4) and Interleukin-13 (IL-13) Cytokines. Journal of Biological Chemistry 288:37, pages 26583-26593.
Crossref
Marta Compte, Natalia Nuñez-Prado, Laura Sanz & Luis Alvarez-Vallina. (2013) In Vivo Secretion of Bispecific Antibodies Recruiting Lymphocytic Effector Cells. Antibodies 2:4, pages 415-425.
Crossref
Dingyi Wen, Susan F. Foley, Xiaoping L. Hronowski, Sheng Gu & Werner Meier. (2013) Discovery and Investigation of O -Xylosylation in Engineered Proteins Containing a (GGGGS) n Linker . Analytical Chemistry 85:9, pages 4805-4812.
Crossref
Eryl Liddell. 2013. The Immunoassay Handbook. The Immunoassay Handbook 245 265 .
Christian Kellner & Matthias Peipp. 2013. Molecular and Cellular Mechanisms of Antibody Activity. Molecular and Cellular Mechanisms of Antibody Activity 251 284 .
Pierre Miossec & Jay K. Kolls. (2012) Targeting IL-17 and TH17 cells in chronic inflammation. Nature Reviews Drug Discovery 11:10, pages 763-776.
Crossref